CompletedPhase 4NCT00810108

Lopinavir/Ritonavir (Kaletra) PK in Children

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Principal Investigator
Brookie Best, PharmD, MAS
University of California, San Diego
Intervention
lopinavir/ritonavir (Kaletra®) tablets(drug)
Enrollment
12 enrolled
Eligibility
6-17 years · FEMALE
Timeline
20062009

Study locations (2)

Collaborators

American Association of Colleges of Pharmacy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00810108 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials